Abvc Biopharma Stock Analysis
| ABVC Stock | USD 3.52 0.17 5.07% |
ABVC Biopharma is overvalued with Real Value of 2.42 and Hype Value of 3.56. The main objective of ABVC Biopharma stock analysis is to determine its intrinsic value, which is an estimate of what ABVC Biopharma is worth, separate from its market price. There are two main types of ABVC Biopharma's stock analysis: fundamental analysis and technical analysis.
The ABVC Biopharma stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and ABVC Biopharma's ongoing operational relationships across important fundamental and technical indicators.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ABVC Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. ABVC Stock Analysis Notes
About 16.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.19. ABVC Biopharma last dividend was issued on the 8th of May 2019. The entity had 1:10 split on the 25th of July 2023. ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. ABVC BioPharma, Inc. is a subsidiary of YuanGene Corporation. Abvc Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 28 people. For more info on ABVC Biopharma please contact Howard MD at 510 668 0881 or go to https://www.abvcpharma.com.ABVC Biopharma Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. ABVC Biopharma's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding ABVC Biopharma or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| ABVC Biopharma is way too risky over 90 days horizon | |
| ABVC Biopharma appears to be risky and price may revert if volatility continues | |
| ABVC Biopharma has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 509.59 K. Net Loss for the year was (5.26 M) with profit before overhead, payroll, taxes, and interest of 507.9 K. | |
| ABVC Biopharma currently holds about 2.99 M in cash with (1.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.09. | |
| ABVC Biopharma has a frail financial position based on the latest SEC disclosures | |
| Roughly 16.0% of the company shares are held by company insiders |
ABVC Biopharma Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to ABVC Biopharma previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 29th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
ABVC Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 56.89 M.Technical Drivers
As of the 21st of July, ABVC Biopharma shows the Coefficient Of Variation of 366.82, market risk adjusted performance of 1.8, and Mean Deviation of 7.36. ABVC Biopharma technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the entity's future prices.ABVC Biopharma Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Simple Moving Average indicator is calculated by adding the closing price of ABVC Biopharma for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out ABVC Biopharma short-term fluctuations and highlight longer-term trends or cycles.
ABVC Biopharma Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ABVC Biopharma insiders, such as employees or executives, is commonly permitted as long as it does not rely on ABVC Biopharma's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases ABVC Biopharma insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
ABVC Biopharma Outstanding Bonds
ABVC Biopharma issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. ABVC Biopharma uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most ABVC bonds can be classified according to their maturity, which is the date when ABVC Biopharma has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
ABVC Biopharma Predictive Daily Indicators
ABVC Biopharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of ABVC Biopharma stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 16337.36 | |||
| Daily Balance Of Power | 0.68 | |||
| Rate Of Daily Change | 1.05 | |||
| Day Median Price | 3.48 | |||
| Day Typical Price | 3.49 | |||
| Price Action Indicator | 0.13 | |||
| Period Momentum Indicator | 0.17 |
ABVC Biopharma Forecast Models
ABVC Biopharma's time-series forecasting models are one of many ABVC Biopharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ABVC Biopharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About ABVC Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how ABVC Biopharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ABVC shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as ABVC Biopharma. By using and applying ABVC Stock analysis, traders can create a robust methodology for identifying ABVC entry and exit points for their positions.
ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. ABVC BioPharma, Inc. is a subsidiary of YuanGene Corporation. Abvc Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 28 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding ABVC Biopharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Volatility Analysis Now
Volatility AnalysisGet historical volatility and risk analysis based on latest market data |
| All Next | Launch Module |
Complementary Tools for ABVC Stock analysis
When running ABVC Biopharma's price analysis, check to measure ABVC Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABVC Biopharma is operating at the current time. Most of ABVC Biopharma's value examination focuses on studying past and present price action to predict the probability of ABVC Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABVC Biopharma's price. Additionally, you may evaluate how the addition of ABVC Biopharma to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |